Johannes Falke - Publications

Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.

Journal: BioMed research international

Published: March 20, 2018

A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.

Journal: World journal of urology

Published: February 28, 2018

Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: December 02, 2017

Pharmacokinetics and pharmacodynamics of intravesical and intravenous TMX-101 and TMX-202 in a F344 rat model.

Journal: Urologic oncology

Published: June 19, 2017

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Journal: World journal of urology

Published: October 03, 2014

Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer.

Journal: Clinical genitourinary cancer

Published: September 22, 2014

The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro study.

Journal: Urologic oncology

Published: May 15, 2013

Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancer.

Journal: The Journal of urology

Published: November 26, 2012